Delivery Order SPE2DB20D9214-SPE2DB25FD4WT
- Not listed
- The Defense Logistics Agency (DLA) has awarded a $2,824.56 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS and is valid through October 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,353.75 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. This delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which enables the agency to issue delivery orders for a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, SPE2DX24FKVPL, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,766.00 contract is to deliver the pharmaceutical product SKYLA 14MCG/24HR 1S. This delivery order is issued against DMS Pharmaceutical Group's indefinite delivery contract, SPE2DB, with DLA valued at up to $4,999,999 through 2025. Under this larger vehicle, DMS provides a broad range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,353.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4566760104 SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance through January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,353.75 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a medical device product. The contract has an ultimate completion date of September 11, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,537.50 firm fixed-price delivery order is for SKYLA 13.5 MG SYSTEMS and has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,718.48 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,644.72 firm fixed-price delivery order is for the procurement of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. The delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the SKYLA 13.5 MG SYSTEMS medical device. The $9,415.00 contract has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription drugs, over-the-counter products, and medical supplies to support military treatment facilities worldwide under various...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,270.70 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product. The award is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valid...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4WTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,486.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for SKYLA 13.5 mg systems. The award, made on August 5, 2025, with an ultimate completion date of August 26, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's SPE2DB program, a $500 million contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA to distribute branded and generic prescription drugs, biologics, medical consumables, and specialty pharmaceutical products to Department of Defense healthcare sites. The company's contract portfolio demonstrates sustained expertise in delivering various pharmaceutical categories including injections, tablets, creams, and auto-injectors. This particular delivery order for SKYLA contraceptive devices continues the company's established role in supplying essential medical products that support the healthcare operations of military facilities across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/5/25 |